Drug intelligence / Profile preview

antipyrine

Development stage
Phase 2
Modality
Small Molecules
Administration
Oral, Otic
01

Overview

Antipyrine is a synthetic analgesic and antipyretic drug that has been used since the late 19th century. It is primarily used for the symptomatic treatment of acute otitis media (middle ear infection), most commonly in combination with benzocaine as an otic (ear) solution to relieve ear pain and swelling. Antipyrine can also be administered orally or as ear drops and has historically been used to test hepatic drug-metabolizing enzyme activity. Its mechanism of action involves inhibition of cyclooxygenase enzymes (COX-1 and COX-2), leading to reduced synthesis of prostaglandins involved in pain and fever signaling[2][5][8]. While it was once widely used as an oral antipyretic/analgesic agent for various indications including fever and mild pain relief[5], its use today is largely limited to topical otologic applications.

Brand names
A/B OticAurodexAurotoBenzoticDec-Agesic A.B.DoloticAuralgan
Other names
phenazonephenazonantipyrinanalgesine
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on antipyrine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on antipyrine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call